Global taxane market is projected to register a substantial CAGR of 7.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.
Market Segmentation:
Global Taxane Market, By Type (Paclitaxel, Docetaxel, Cabazitaxel), Drug Type (Generics, Branded), Formulation (Liposomes, Nanoparticles, Polymeric Micelles, Others), Age Group (Adults, Geriatric), Application (Breast Cancer, Non-Small Lung Cancer, Pancreatic Cancer, Ovarian Cancer, Prostate Cancer, Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others) Distribution Channel (Retail Sales, Direct Tender), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Poland, Austria, Hungary, Lithuania, Norway, Ireland, Rest of Europe, China, Japan, India, South Korea, Singapore, Thailand, Vietnam, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, UAE, Egypt, Israel, South Africa, Kuwait, Rest of Middle East and Africa, Brazil, Argentina, Peru, and Rest of South America) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the global taxane market are:
The rise in the incidence of cancer
The funding by the government and investment in research and development
Market Segmentation:
Global taxane market is categorized into seven notable segment which are based on type, drug type, formulation, age group, application, end user and distribution channel
On the basis of type, the global taxane market is segmented into paclitaxel, docetaxel and cabazitaxel
On the basis of application, the global taxane market is segmented into ovarian cancer, breast cancer, prostate cancer, non-small cell lung cancer and other
On the basis of drug type, the global taxane market is segmented into branded and generics
On the basis of formulation, the global taxane market is segmented into liposomes, nanoparticles, polymeric micelles and others
On the basis of age group, the global taxane market is segmented into adults and geriatric
On the basis of end user, the global taxane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others
On the basis of distribution channel, the global taxane market is segmented into direct tender, retail sales
Market Players:
The key market players for global taxane market are listed below:
Viatris Inc.
Sandoz International GmbH ( A Novartis Division)
sanofi-aventis U.S. LLC
Hikma Pharmaceuticals PLC
Pfizer Inc.
Dr. Reddys Laboratories Ltd.
Taxane Healthcare
Bristol-Myers Squibb Company
Fresenius Kabi AG (Subsidiary of Fresenius SE & Co. KGaA )
SAMYANG HOLDINGS CORPORATION.
Luye Pharma Group
Elevar Therapeutics
Huiang Pharmaceutical Co Ltd.
Shenzhen Main Luck Phar maceuticals Inc.
Accord Healthcare
Torrent Pharmaceuticals Ltd.
Panacea Biotec
RPG Life Sciences Limited.
Aureate Healthcare
Samarth Life Sciences Pvt. Ltd.
Cipla Inc.
Hetero Healthcare Limited.
AqVida GmbH
Ingenus Pharmaceuticals, LLC
TABLE OF CONTENT
Segmentation
Short Description
Global Taxane Market, By Type (Paclitaxel, Docetaxel, Cabazitaxel), Drug Type (Generics, Branded), Formulation (Liposomes, Nanoparticles, Polymeric Micelles, Others), Age Group (Adults, Geriatric), Application (Breast Cancer, Non-Small Lung Cancer, Pancreatic Cancer, Ovarian Cancer, Prostate Cancer, Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others) Distribution Channel (Retail Sales, Direct Tender), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Poland, Austria, Hungary, Lithuania, Norway, Ireland, Rest of Europe, China, Japan, India, South Korea, Singapore, Thailand, Vietnam, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, UAE, Egypt, Israel, South Africa, Kuwait, Rest of Middle East and Africa, Brazil, Argentina, Peru, and Rest of South America) Industry Trends and Forecast to 2029
Market Definition:
The taxanes or taxoids are a closely related group of antineoplastic agents that have a unique mechanism of action as inhibitors of mitosis and which are widely used in the therapy of ovarian, breast, lung, esophageal, prostate, bladder, and head and neck cancers. Three taxanes are in clinical use, paclitaxel (Taxol: 1992), docetaxel (Taxotere: 1996) and cabazitaxel (Jevtana: 2010). Taxanes are anticancer drugs that interfere with microtubule function, causing changes in mitosis and cellular death. Paclitaxel (Taxol) was first isolated from a yew tree, a small evergreen coniferous tree with a slow growth rate. As paclitaxel was initially scarce, docetaxel (Taxotere), a semisynthetic analogue of paclitaxel derived from the needles of the European yew tree Taxus baccata, was created. Docetaxel differs from paclitaxel in two chemical locations, making it more water soluble. Lung cancer, prostate cancer, squamous cell carcinoma of the head and neck, breast cancer, Kaposi's sarcoma, gastric cancer, bladder cancer, esophageal cancer and other carcinomas are all commonly treated with paclitaxel and docetaxel. Cabazitaxel is also a semisynthetic analogue of natural taxoids and was developed for its lack of affinity for P-glycoprotein, a common mediator of docetaxel resistance.
Market Segmentation:
The global taxane market is categorized into seven notable segments which are based on type, drug type, formulation, age group, application, end user and distribution channel.
On the basis of type, the global taxane market is segmented into paclitaxel, docetaxel and cabazitaxel
On the basis of drug type, the global taxane market is segmented into branded and generics
On the basis of formulation, the global taxane market is segmented into liposomes, nanoparticles, polymeric micelles, others
On the basis of age group, the global taxane market is segmented into adults and geriatric
On the basis of application, the global taxane market is segmented into ovarian cancer, breast cancer, prostate cancer, pancreatic cancer, non-small cell lung cancer and others
On the basis of end user, the global taxane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others
On the basis of distribution channel, the global taxane market is segmented into direct tender, retail sales
Market Players
Some of the major players operating in the global taxane market are:
Viatris Inc.
Sandoz International GmbH (A Novartis Division)
sanofi-aventis U.S. LLC
Hikma Pharmaceuticals PLC
Pfizer Inc.
Dr. Reddys Laboratories Ltd.
Taxane Healthcare
Bristol-Myers Squibb Company
Fresenius Kabi AG (Subsidiary of Fresenius SE & Co. KGaA)
SAMYANG HOLDINGS CORPORATION.
Luye Pharma Group
Elevar Therapeutics
Huiang Pharmaceutical Co Ltd.
Shenzhen Main Luck Pharmaceuticals Inc.
Accord Healthcare
Torrent Pharmaceuticals Ltd.
Panacea Biotec
RPG Life Sciences Limited.
Aureate Healthcare
Samarth Life Sciences Pvt. Ltd.
Cipla Inc.
Hetero Healthcare Limited.
AqVida GmbH
Ingenus Pharmaceuticals, LLC
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
